Hi there GPCR enthusiasts! Join us this week for a deep dive into the world of GPCRs. This week's GPCR papers feature publications from Drs. Ines Liebscher, Ross Cheloha and Silvio Gutkind.
Before we dive into this week’s news, we’d like to draw your attention to some of our events and resources:
Please mark your calendars for July 21st for our next Dr. GPCR Symposium on Structural and Molecular Insights on GPCR Activation. Our website is updated as we confirm speakers so please check back often. We also seek speakers and poster presenters for the next symposium and beyond! Showcase your work by emailing us at Hello@DrGPCR.com.
Stay updated with Dr. GPCR News by subscribing to our monthly newsletter.
Our founder Dr. Yamina A. Berchiche is at the Molecular Pharmacology GRC, if you are also on-site, please stop by and say hi.
And now let’s dive into the weekly Classified GPCR News at a glance for June 5th to June 11th, 2023.
Altered Signaling and Desensitization Responses in PTH1R Mutants Associated with Eiken Syndrome
Antagonistic interactions between odorants alter human odor perception.
Autocrine Proteinase-Activated Receptor (PAR) signaling in PC3 prostate cancer cells.
Statin-induced increase in actin polymerization modulates GPCR dynamics and compartmentalization.
GPCRs in drug discovery: challenges & solutions (June 19 - 23, 2023)
Training School on “Cell-based assays to study Adhesion GPCR function". (June 28 - 30, 2023)
FREE 11th Adrenoceptor Symposium: Adrenoceptors and GPCR Signalling (June 30 - July 1, 2023)
19th World Congress of Basic & Clinical Pharmacology 2023. (July 2 - 7, 2023).
Comentarios